Health
RFK Jr.’s vaccine panel postpones vote on whether to delay babies’ first hepatitis B shot
Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine panel on Friday postponed a vote on whether to delay the first dose of the hepatitis B shot from birth to at least one month for most babies born in the U.S. The decision means that the committee’s current recommendation – that all infants […]
Read More
Covid shot access, coverage at stake as RFK Jr.’s hand-picked vaccine panel convenes
Ruth Jones, immunization nurse, holds a Pfizer-BioNTech COVID-19 vaccine (brand name: Comirnaty) at Borinquen Health Care Center in Miami, Florida, on May 29, 2025. Joe Raedle | Getty Images Covid shot access and coverage in the U.S. hang in the balance as an influential government vaccine panel hand-picked by Health and Human Services Secretary Robert […]
Read More
Novo Nordisk shares pop 5% after Wegovy pill trial shows ‘significant’ weight reduction
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk said Wednesday that late-stage trial results […]
Read More
Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Wednesday said its experimental pill outperformed Novo Nordisk‘s own oral drug in the first head-to-head study comparing the two medicines in patients with Type 2 diabetes. The […]
Read More
Healthy Returns: What to know about RFK Jr.’s five new vaccine panel members
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., testifies before a Senate Finance Committee hearing on President Donald Trump’s 2026 health care agenda, on Capitol Hill in Washington, D.C., U.S., September 4, 2025. Jonathan Ernst | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest […]
Read More
Jim Cramer says Eli Lilly’s obesity pill could be more of a ‘lifetime drug’ than shots
Don’t count out Eli Lilly’s oral GLP-1 drug for obesity and diabetes just yet, according to CNBC’s Jim Cramer . That was his takeaway following the latest study involving Lilly’s orforglipron, the experimental pill that has been the subject of Wall Street debate since weight-loss data released in early August came in below investor expectations. […]
Read More
Wegovy-maker Novo Nordisk to cut around 9,000 jobs
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images Danish pharmaceutical giant Novo Nordisk on Wednesday announced plans to cut around 9,000 roles, or roughly 11.5% of its global workforce. “Novo Nordisk today announced a company-wide transformation to simplify its organisation, improve the speed […]
Read More
UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says
U.S. policymakers should take note as biopharmaceutical companies pull back on investments in the U.K., Eli Lilly Chief Executive Officer Dave Ricks said in an interview with CNBC. Lilly recently paused plans to create a biotech incubator called Gateway Labs in the U.K., joining other biopharma companies that have put investments in the country on […]
Read More
Eli Lilly to build $5 billion Virginia facility to boost production of targeted cancer drugs, other treatments
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments — the first in a string of new […]
Read More
Novo Nordisk flags drug trial promise amid hunt for next weight-loss blockbuster
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy is seen outside theri building as the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk on Wednesday flagged promising late-stage […]
Read More